MTOR and Miyoshi myopathy: To our knowledge the involvement of RARRES3 and β-catenin in mediating the effects of dual PI3K/mTOR inhibitors have not been identified before and will contribute further insights to the mechanism of action of these inhibitors in MM as well as other cancers.